AIB
AIBCIK 0002070542
Small by assets
Assets $90M
as of Oct 11, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
8-K
Filed Oct 7, 2026
· Period ending Oct 7, 2026
Summary not yet generated.
8-K
Filed Oct 1, 2026
· Period ending Sep 30, 2026
Summary not yet generated.
Partner
Trade AIB commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Sep 30, 2026
· Period ending Sep 30, 2026
Summary not yet generated.
8-K
Filed Sep 11, 2026
· Period ending Sep 4, 2026
Summary not yet generated.
8-K
Filed Sep 10, 2026
· Period ending Sep 10, 2026
Summary not yet generated.
8-K
Filed Aug 21, 2026
· Period ending Aug 19, 2026
Summary not yet generated.
8-K
Filed Aug 19, 2026
· Period ending Aug 19, 2026
Summary not yet generated.
10-Q
Filed Aug 13, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Aug 5, 2026
· Period ending Jul 22, 2026
Summary not yet generated.
8-K
Filed Jul 8, 2026
· Period ending Jul 8, 2026
Summary not yet generated.
S-1/A
Filed Jun 3, 2026
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 13, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenues (Note 5) | 2,915,460 | 4,744,627 | 7,828,661 | 9,244,269 |
| Costs and operating expenses: | ||||
| Cost of revenues | 3,432,555 | 4,196,007 | 7,775,997 | 7,469,329 |
| Depreciation and amortization (Note 3) | 250,910 | 193,809 | 501,011 | 356,981 |
| Selling, general and administrative expenses | 2,710,592 | 896,623 | 3,307,576 | 1,533,346 |
| Advertising expense | 101,406 | - | 101,406 | - |
| Total costs and operating expenses | 6,495,463 | 5,286,439 | 11,685,990 | 9,359,656 |
| Loss from operations | (3,580,003) | (541,812) | (3,857,329) | (115,387) |
| Other income (expense) | ||||
| Gain on disposal of assets held for sale (Note 3) | - | - | - | 67,714 |
| Other income (expense) | 98,770 | - | 102,898 | (5,360) |
| Total other income | 98,770 | - | 102,898 | 62,354 |
| Net loss attributable to common stockholders | (3,481,233) | (541,812) | (3,754,431) | (53,033) |
| Basic and diluted loss per share | (0.07) | (0.01) | (0.09) | (0.00) |
| Basic and diluted weighted average number of shares outstanding | 46,840,272 | 37,646,133 | 42,268,601 | 37,646,133 |
Condensed Consolidated Balance Sheets
| Description | June 30, 2026 (Unaudited) | December 31, 2025 (Audited) |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 52,784,510 | 15,265 |
| Accounts receivable | 740,224 | 7,720 |
| Due from related party, net (Note 11) | 1,698,329 | 2,144,506 |
| Loan receivable related party (Note 11) | 1,083,460 | 1,083,460 |
| Prepaid expenses and other current assets (Note 11) | 1,401,828 | 218,698 |
| Total current assets | 57,708,351 | 3,469,649 |
| Property and equipment, net (Note 3) | 8,771,622 | 8,865,019 |
| Goodwill (Note 4) | 23,874,326 | 4,851,136 |
| Operating lease right-of-use asset (Note 6) | 27,268 | 81,712 |
| Other assets | 26,200 | - |
| Total assets | 90,407,767 | 17,267,516 |
| Liabilities and stockholders’ equity: | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | 2,635,633 | 3,304,012 |
| Contract liabilities (Note 5) | - | 2,330,584 |
| Consideration payable, current portion (Note 3) | 1,166,001 | 1,166,001 |
| Operating lease liability, current portion (Note 6) | 27,269 | 81,712 |
| Other current liabilities | 3,814,852 | 1,845,760 |
| Total current liabilities | 7,643,755 | 8,728,069 |
| Consideration payable, net of current portion (Note 3) | 97,167 | 680,166 |
| Total liabilities | 7,740,922 | 9,408,235 |
| Commitments and contingencies (see Note 10) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 100,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025 (Note 9) | - | - |
| Common stock, $0.0001 par value; 1,000,000,000 shares authorized; 75,979,466 shares issued and outstanding as of June 30, 2026; no shares issued and outstanding as of December 31, 2025 (Note 9) | 7,599 | - |
| Additional paid in capital | 86,413,677 | - |
| (Accumulated deficit) retained earnings | (3,754,431) | 7,859,281 |
| Total stockholders’ equity | 82,666,845 | 7,859,281 |
| Total liabilities and stockholders’ equity | 90,407,767 | 17,267,516 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | (3,754,431) | (53,033) |
| Adjustments to reconcile net loss to net cash and cash equivalents provided by operating activities: | ||
| Depreciation and amortization | 501,011 | 356,981 |
| Gain on disposal of assets held for sale (Note 3) | - | (67,714) |
| Non-cash advisory shares (Note 4) | 650,642 | - |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (276,781) | (525,627) |
| Prepaid expenses and other current assets | 42,738 | 36,920 |
| Operating lease right of use asset | 54,444 | - |
| Accounts payable and accrued expenses | (1,472,069) | 654,086 |
| Contract liabilities | (2,332,010) | (1,638,517) |
| Lease liability | (54,443) | - |
| Other current liabilities | 1,969,092 | 247,623 |
| Net cash used in operating activities | (4,671,807) | (989,281) |
| Cash flows from investing activities: | ||
| Cash acquired in reverse merger (Note 4) | 253,214 | - |
| Payment of land deposit (Note 11) | (1,200,000) | - |
| Proceeds from sale of assets held for sale (Note 3) | - | 132,000 |
| Proceeds from loan receivable related party | - | 996,146 |
| Net cash (used in) / provided by investing activities | (946,786) | 1,128,146 |
| Cash flows from financing activities: | ||
| Contributions | - | 1,174,085 |
| Distributions | - | (1,442,600) |
| Proceeds from public offering, net (Note 9) | 58,970,837 | - |
| Repayments of consideration payable | (582,999) | - |
| Net cash provided by / (used in) financing activities | 58,387,838 | (268,515) |
| Net increase (decrease) in cash and cash equivalents | 52,769,245 | (129,650) |
| Cash and cash equivalents, beginning of period | 15,265 | 131,107 |
| Cash and cash equivalents, end of period | 52,784,510 | 1,457 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Non-cash additions to construction in progress included in accounts payable and accrued expenses | 400,000 | - |
| Acquisition of property and equipment through deferred payment arrangement | - | 2,332,000 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗